# Ingenus Pharmaceuticals GmbH, Barbengo, Switzerland – FDA Inspections

Source: https://www.keypedia.com/companies/ingenus-pharmaceuticals-gmbh/2255ec6f-3349-4a71-be33-91a83420b530

> Inspection records and compliance data for Ingenus Pharmaceuticals GmbH in Barbengo. 5 FDA inspections on record, 2 Form 483s, last inspected October 03, 2024.

---

## Details

- Name: Ingenus Pharmaceuticals GmbH
- FEI Number: 3005403232
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK
- Address Line 1: Via Cadepiano 24
- City: Barbengo
- Country Name: Switzerland
- Address: Via Cadepiano 24, Barbengo, Switzerland
- Country: Switzerland

## Related Documents

- FDA Inspection 1263921 - Ingenus Pharmaceuticals GmbH - 2024-10-03 — source: FDA, date: October 3, 2024
- FDA Inspection 1263921 - Ingenus Pharmaceuticals GmbH - 2024-10-03 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 3, 2024
- FDA Inspection 1115845 - Ingenus Pharmaceuticals GmbH - 2019-12-03 — classification: No Action Indicated (NAI), source: FDA, date: December 3, 2019
- [FDA Inspection 1074093 - Ingenus Pharmaceuticals GmbH - 2018-12-11](https://www.keypedia.com/records/fda_inspections/ingenus-pharmaceuticals-gmbh/77f0d2b8-0f1b-47cc-a2e6-7b9415943972) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 11, 2018
- [FDA Inspection 1034770 - Ingenus Pharmaceuticals GmbH - 2017-10-31](https://www.keypedia.com/records/fda_inspections/ingenus-pharmaceuticals-gmbh/8c8bead2-8a44-454f-86a5-e331f7849dd1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 31, 2017
- FDA Inspection 905257 - Ingenus Pharmaceuticals GmbH - 2014-11-04 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 4, 2014

## Related Companies

- [Fareva Pau](https://www.keypedia.com/companies/fareva-pau/410f25e1-0b2b-4465-923c-a1a053a0a35d)
- [Solupharm Pharmazeutische Erzeugnisse Gmbh](https://www.keypedia.com/companies/solupharm-pharmazeutische-erzeugnisse-gmbh/dd3d4b95-d76b-4afa-b430-f1dee1ebb184)
- [Akeso-Sino Pharma Co., Ltd.](https://www.keypedia.com/companies/akeso-sino-pharma-co-ltd/9bb4a29a-ab23-4ff4-a070-8bfba127e904)
- [Glaxo Operations U.K. Ltd.](https://www.keypedia.com/companies/glaxo-operations-uk-ltd/5c8a39c9-a63a-4574-885a-c16948f20589)
- [Cenexi](https://www.keypedia.com/companies/cenexi/8f8d0957-8524-4fdd-a1c2-2d5b4023ce49)
- [Pharmachemie B.V. dba Teva Pharmachemie](https://www.keypedia.com/companies/pharmachemie-bv-dba-teva-pharmachemie/5c4e4cb7-d7a7-4513-aaa8-514e1264f180)
- [TevaRuncorn](https://www.keypedia.com/companies/tevaruncorn/275f62ca-3a9a-42c5-833e-0b8bd9c77831)
- [B Braun Melsungen Ag- Aktiengesellschaft](https://www.keypedia.com/companies/b-braun-melsungen-ag-aktiengesellschaft/1a2b15e4-288a-426d-a9d6-7b7bbf698315)
- [Bridgewest Perth Pharma Pty Ltd.](https://www.keypedia.com/companies/bridgewest-perth-pharma-pty-ltd/9cbc4ae0-049d-4911-95d5-bb44a477346e)
- [Cenexi Laboratoires Thissen SA](https://www.keypedia.com/companies/cenexi-laboratoires-thissen-sa/83fd3547-ba88-47a3-bc18-1658ed5b3c05)